Mersana Therapeutics, Inc.
Records under this name other than the patents Mersana Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 28 patents it holds.
Back to Mersana Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,316,080 | Protein-Polymer-Drug Conjugates Formerly held In force · High confidence | In force | High confidence | |
| US 11,434,278 | Protein-Polymer-Drug Conjugates Formerly held Lapsed on the fee record Ended Sep 6, 2026 · Low confidence | Lapsed on the fee record | Ended Sep 6, 2026 | Low confidence |
| US 8,815,226 | Protein-Polymer-Drug Conjugates Lapsed on the fee record Ended Aug 26, 2026 · High confidence | Lapsed on the fee record | Ended Aug 26, 2026 | High confidence |
| US 11,407,825 | NaPi2B-TARGETED POLYMER ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF Lapsed on the fee record Ended Aug 9, 2026 · High confidence | Lapsed on the fee record | Ended Aug 9, 2026 | High confidence |
| US 9,872,918 | Hydroxyl-polymer-drug-protein conjugates Lapsed on the fee record Ended Jan 23, 2026 · USPTO record | Lapsed on the fee record | Ended Jan 23, 2026 | USPTO record |
| US 10,660,901 | Pyrrolobenzodiazepines and conjugates thereof Lapsed on the fee record Ended May 26, 2024 · USPTO record | Lapsed on the fee record | Ended May 26, 2024 | USPTO record |
| US 9,808,528 | Protein-polymer-drug conjugates and methods of using same Lapsed on the fee record Ended Nov 7, 2021 · USPTO record | Lapsed on the fee record | Ended Nov 7, 2021 | USPTO record |
| US 8,524,214 | Polyal drug conjugates comprising variable rate-releasing linkers Lapsed on the fee record Ended Sep 3, 2021 · USPTO record | Lapsed on the fee record | Ended Sep 3, 2021 | USPTO record |
| US 7,785,618 | Conjugates Comprising a Biodegradable Polymer and Uses Therefor Lapsed on the fee record Ended Aug 31, 2018 · High confidence | Lapsed on the fee record | Ended Aug 31, 2018 | High confidence |
| US 8,491,880 | Pharmaceutical formulations of biodegradable biocompatible camptothecin-polymer conjugates Lapsed on the fee record Ended Jul 23, 2017 · USPTO record | Lapsed on the fee record | Ended Jul 23, 2017 | USPTO record |